Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy. [electronic resource]
Producer: 20210111Description: 1473-1479 p. digitalISSN:- 1724-6016
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Choroid -- blood supply
- Choroid Diseases -- diagnosis
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Fundus Oculi
- Humans
- Intravitreal Injections
- Male
- Photochemotherapy -- methods
- Polyps -- diagnosis
- Ranibizumab -- administration & dosage
- Receptors, Vascular Endothelial Growth Factor -- administration & dosage
- Recombinant Fusion Proteins -- administration & dosage
- Retrospective Studies
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.